24th November 2014 – Cancer pharmacist prestigious study trip

Posted on November 24, 2014 by AireAdmin

24th November 2014

Cancer pharmacist prestigious study trip

A clinical pharmacist from Airedale Hospital has scooped a national award which will pay for a study trip to Vienna. Carl Booth has won a travel scholarship for his cancer research study which he presented in poster format to members of BOPA – the British Oncology Pharmacy Association.

The lead pharmacist for cancer services at Airedale NHS Foundation Trust and  executive committee member of BOPA,  who recently become the chair of the BOPA audit research committee, had to present his study at a meeting in Birmingham.

It was members of BOPA from throughout the country who voted for his presentation as the winner. He will now travel to the European Society of Medical Oncology’s (ESMO) annual conference held in Austria in September 2015 and report back his findings to BOPA so all members can benefit from his experience.

Carl’s presentation was about a scoring system for assessing the risk of thrombosis for patients undergoing chemotherapy to decide whether they should be prescribed heparin – a drug used to treat and prevent blood clots in the veins. The plan is to use the scoring system for 50 patients and then follow the progress of these patients throughout their cancer treatment.

Carl said he was very excited about attending the next ESMO as it is a major four day event, attracting around 15,000 participants, where the latest news from clinical trials, new drugs and developments in cancer care are announced.

This is the second time that Carl, aged 46, of Cowling, has won the award. He said: “I’m delighted to be going to the conference as it’s such a great opportunity to learn about the latest developments in cancer care and research in the field.

“There was tough competition in the poster presentations. Hopefully others will be able to learn from my presentation and be able to implement the scoring system.  If it is rolled out to larger numbers it becomes more credible as research.

“My new role in BOPA is to try and get other pharmacists to work together on research projects as we will get better results if they are coordinated.

“Currently there are a lots of people involved in small projects but if start to work with bigger numbers this will mean more meaningful research. Hopefully it will show other pharmacists that you don’t have to work at a large cancer centre to make a difference to care of patients.”

Ends